Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Geron Corporation
Geron Corporation
National Cancer Institute (NCI)
Swedish Orphan Biovitrum
Bellicum Pharmaceuticals
M.D. Anderson Cancer Center
Swedish Orphan Biovitrum
Roswell Park Cancer Institute
Kiadis Pharma
Hoffmann-La Roche